SOHM India, a subsidiary of the USA-based generics drugmaker SOHM Inc (Pinksheet: SHMN), has successfully executed a bulk purchase order and delivered the first 2 million tablets of sildenafil citrate 100mg, a copy version of the active ingredient in Pfizer’s top-selling erectile dysfunction drug Viagra, in West Africa. The pharmaceutical order is expected to drive revenue in 2010 and 2011 as future orders are delivered. The purchase order marks a significant step in obtaining market share in West Africa's $2.5 billion pharmaceutical market.
Earlier this year, California-based SOHM signed a sales and marketing agreement to sell its branded generic pharmaceutical products in Africa, although it did not name its new partner (The Pharma Letter May 25).
Comprising almost a third of the whole continent, West Africa is a region with a population of approximately 250 million. Imports of finished products account for over 60% of the African pharmaceutical industry. According to IMS forecast, Nigeria's Pharmaceutical business is worth $2.5 billion serving 150 million Nigerians. The pharmaceutical market in West Africa has been growing 5%-7% annually, the company noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze